The scrum between Ariosa Diagnostics Inc. and Illumina Inc. over patents pertaining to noninvasive prenatal tests has several years of history behind it, but the two companies may not be done with each other just yet. Ariosa petitioned the U.S. Supreme Court to review the question of what constitutes the date of prior art, an important policy question the court could answer in a manner that invalidates a large number of patents.